Literature DB >> 17067834

alpha2delta and the mechanism of action of gabapentin in the treatment of pain.

Y P Maneuf1, Z D Luo, K Lee.   

Abstract

Gabapentin is a drug that has been widely used in the treatment of chronic pain states. Despite its widespread usage, it is only recently that light has been shed on the mechanism of action of this agent. In the current review, the authors document the pharmacological, biochemical and molecular information that has led to the identification of the alpha2delta1 auxilliary subunit of voltage gated calcium channels as the target for this drug's actions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067834     DOI: 10.1016/j.semcdb.2006.09.003

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  20 in total

1.  Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer.

Authors:  Heather M Starmer; WuYang Yang; Raju Raval; Christine G Gourin; Marian Richardson; Rachit Kumar; Bronwyn Jones; Todd McNutt; Zhi Cheng; Sierra Cheng; Harry Quon
Journal:  Dysphagia       Date:  2014-03-15       Impact factor: 3.438

Review 2.  Oxycodone combinations for pain relief.

Authors:  R B Raffa; J V Pergolizzi; D J Segarnick; R J Tallarida
Journal:  Drugs Today (Barc)       Date:  2010-06       Impact factor: 2.245

3.  Gabapentin decreases epileptiform discharges in a chronic model of neocortical trauma.

Authors:  Huifang Li; Kevin D Graber; Sha Jin; Whitney McDonald; Ben A Barres; David A Prince
Journal:  Neurobiol Dis       Date:  2012-07-02       Impact factor: 5.996

Review 4.  HCN Channel Targets for Novel Antidepressant Treatment.

Authors:  Stacy M Ku; Ming-Hu Han
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

5.  Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain.

Authors:  Wahida Rahman; Claudia S Bauer; Kirsty Bannister; Jean-Laurent Vonsy; Annette C Dolphin; Anthony H Dickenson
Journal:  Mol Pain       Date:  2009-08-07       Impact factor: 3.395

6.  Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.

Authors:  Raymond F Anton; Patricia Latham; Konstantin Voronin; Sarah Book; Michaela Hoffman; James Prisciandaro; Emily Bristol
Journal:  JAMA Intern Med       Date:  2020-05-01       Impact factor: 21.873

7.  Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide.

Authors:  Weina Ju; Qi Li; Yohance M Allette; Matthew S Ripsch; Fletcher A White; Rajesh Khanna
Journal:  J Neurochem       Date:  2013-01-20       Impact factor: 5.372

8.  Recent Developments in Neuropathic Pain Mechanisms: Implications for Treatment.

Authors:  Wahida Rahman; Anthony H Dickenson
Journal:  Rev Pain       Date:  2011-06

9.  Gabapentin Therapy in Psychiatric Disorders: A Systematic Review.

Authors:  Rachel K Berlin; Paul M Butler; Michael D Perloff
Journal:  Prim Care Companion CNS Disord       Date:  2015-10-22

10.  Tri-partite complex for axonal transport drug delivery achieves pharmacological effect.

Authors:  Aaron G Filler; Garth T Whiteside; Mark Bacon; Martyn Frederickson; Franklyn A Howe; Miri D Rabinowitz; Alan J Sokoloff; Terrence W Deacon; Chris Abell; Raj Munglani; John R Griffiths; B Anthony Bell; Andrew M L Lever
Journal:  BMC Neurosci       Date:  2010-01-20       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.